COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics?

Jan M. Schwab(The Ohio State University Wexner Medical Center), Charles N. Serhan(Brigham and Women's Hospital), Richard Meyermann(University of Tübingen), Hermann J. Schluesener
Prostaglandins Leukotrienes and Essential Fatty Acids
October 22, 2003
10.1016/j.plefa.2003.07.003
Cited by 65

Related Papers

Resolvin E1 and protectin D1 activate inflammation-resolution programmes
|Nature|2007|1.2k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
|Cell|2012|572
Lipid Mediators in the Resolution of Inflammation
|Cold Spring Harbor Perspectives in Biology|2014|549